Company profile
Minaris
- Industry
- Pharmaceutical Manufacturing
- Employees
- 803
- Headquarters
- Philadelphia, Pennsylvania
- LinkedIn followers
- 33,443
- Office locations
- 4
Minaris company summary
Minaris is a company in the Pharmaceutical Manufacturing industry, headquartered in Philadelphia, Pennsylvania. On LinkedIn the company has around 803 employees and 33,443 followers. The company lists 4 office locations. Its listed specialties include cGMP Commercial Manufacturing, cGMP Process, Product, Assay Development, GTP Cell and Tissue Processing and Sourcing.
What technology does Minaris use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Minaris
Minaris is a global cell and gene therapy (CGT) CDMO and a multimodality biosafety testing provider. With more than 25 years of CGT development and manufacturing expertise and more than 40 years in biosafety testing, Minaris combines deep legacy experience with state-of-the-art GMP facilities, and is a fully US-owned organization under new ownership and management, built for today’s evolving therapeutic landscape. Our CDMO team supports CGT innovators from IND through commercial supply, and our testing business delivers GMP analytics, biosafety, viral clearance, and product characterization across CGT and biologics. With 5 global sites on 3 continents, we operate with one mission—to support clinical and commercial therapeutic programs hand in hand with our partners to get more therapies to more patients. We are united by our commitment to excellence, reliability, and a patient-focused purpose as we enable innovators to deliver new therapies and expand patient access worldwide. For more information, visit https://minaris.com. Minaris Advanced Therapies is wholly owned by Altaris, LLC.
Specialties
Where is Minaris located?
Minaris lists 4 office locations.
Compare companies similar to Minaris
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Minaris minaris.com | Pharmaceutical Manufacturing | 803 | - | Philadelphia, Pennsylvania |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about Minaris
What does Minaris do?
Minaris is a global cell and gene therapy (CGT) CDMO and a multimodality biosafety testing provider. With more than 25 years of CGT development and manufacturing expertise and more than 40 years in biosafety testing, Minaris combines deep legacy experience with state-of-the-art GMP facilities, and is a fully US-owned organization under new ownership and management, built for today’s evolving therapeutic landscape. Our CDMO team supports CGT innovators from IND through commercial supply, and our testing business delivers GMP analytics, biosafety, viral clearance, and product characterization across CGT and biologics. With 5 global sites on 3 continents, we operate with one mission—to support clinical and commercial therapeutic programs hand in hand with our partners to get more therapies to more patients. We are united by our commitment to excellence, reliability, and a patient-focused purpose as we enable innovators to deliver new therapies and expand patient access worldwide. For more information, visit https://minaris.com. Minaris Advanced Therapies is wholly owned by Altaris, LLC.
How many employees does Minaris have?
Minaris has around 803 employees on LinkedIn.
Where is Minaris headquartered?
Minaris is headquartered in Philadelphia, Pennsylvania.
Where does Minaris have offices?
Minaris lists 4 office locations, including Philadelphia, Pennsylvania, US; Allendale, New Jersey, US; Ottobrunn, Bavaria, DE; Yokohama, 221-0024, JP.
Build a lead list from companies like Minaris
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.